Eli Lilly and Co (LLY)
734.97
-20.94
(-2.77%)
USD |
NYSE |
May 03, 16:00
738.49
+3.52
(+0.48%)
Pre-Market: 20:00
Eli Lilly Market Cap: 698.52B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 698.52B |
| May 02, 2024 | 718.42B |
| May 01, 2024 | 738.23B |
| April 30, 2024 | 742.36B |
| April 29, 2024 | 700.64B |
| April 26, 2024 | 697.13B |
| April 25, 2024 | 688.92B |
| April 24, 2024 | 695.89B |
| April 23, 2024 | 708.71B |
| April 22, 2024 | 695.06B |
| April 19, 2024 | 690.29B |
| April 18, 2024 | 708.95B |
| April 17, 2024 | 713.53B |
| April 16, 2024 | 709.70B |
| April 15, 2024 | 713.53B |
| April 12, 2024 | 714.36B |
| April 11, 2024 | 721.92B |
| April 10, 2024 | 724.19B |
| April 09, 2024 | 719.68B |
| April 08, 2024 | 738.74B |
| April 05, 2024 | 745.32B |
| April 04, 2024 | 729.99B |
| April 03, 2024 | 737.50B |
| April 02, 2024 | 726.07B |
| April 01, 2024 | 722.83B |
| Date | Value |
|---|---|
| March 28, 2024 | 739.66B |
| March 27, 2024 | 739.87B |
| March 26, 2024 | 736.75B |
| March 25, 2024 | 735.08B |
| March 22, 2024 | 732.67B |
| March 21, 2024 | 732.34B |
| March 20, 2024 | 734.81B |
| March 19, 2024 | 734.73B |
| March 18, 2024 | 725.11B |
| March 15, 2024 | 717.04B |
| March 14, 2024 | 723.28B |
| March 13, 2024 | 720.53B |
| March 12, 2024 | 717.78B |
| March 11, 2024 | 698.21B |
| March 08, 2024 | 724.62B |
| March 07, 2024 | 741.75B |
| March 06, 2024 | 741.38B |
| March 05, 2024 | 739.31B |
| March 04, 2024 | 753.27B |
| March 01, 2024 | 743.61B |
| February 29, 2024 | 716.57B |
| February 28, 2024 | 720.34B |
| February 27, 2024 | 726.88B |
| February 26, 2024 | 733.45B |
| February 23, 2024 | 731.19B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
102.65B
Minimum
Oct 10 2019
753.27B
Maximum
Mar 04 2024
279.11B
Average
235.81B
Median
Jul 28 2021
Market Cap Benchmarks
| Amgen Inc | 166.99B |
| Biogen Inc | 31.67B |
| Madrigal Pharmaceuticals Inc | 4.573B |
| Vertex Pharmaceuticals Inc | 103.60B |
| Viking Therapeutics Inc | 8.487B |
Market Cap Related Metrics
| PE Ratio | 110.09 |
| PS Ratio | 18.46 |
| PEG Ratio | 13.99 |
| Price to Book Value | 54.52 |
| Price | 734.97 |
| Earnings Yield | 0.91% |
| PEGY Ratio | 12.94 |
| Operating PE Ratio | 55.10 |
| Normalized PE Ratio | 72.50 |